SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?


To: George Sepetjian who wrote (615)5/12/1998 3:38:00 PM
From: George Sepetjian  Read Replies (1) | Respond to of 3202
 
Another Upgrade


Incyte Pharmaceuticals Raised to 'Buy' at Furman Selz

Princeton, New Jersey, May 12 -- Incyte Pharmaceuticals Inc. (INCY US)
was raised to ''buy'' from ''hold'' by analyst Jonas V. Alsenas at Furman Selz Inc. The
12-month target price is $46.00 per share.